New Method for Detecting Antibiotic Resistance: Mutations Emit Light Signals

Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Universities of Heidelberg and Bielefeld, Germany, have developed a highly sensitive test for detecting this genetic alteration at the level of a single molecule, thus providing information about the resistance status of an infected person.

Many resistances to antibiotics are based on specific mutations in the genetic material of the infectious agents. In the case of life-threatening infections it is vital to determine rapidly which medication will work for the patient. However, commonly used methods of resistance detection are too time-consuming, particularly with microorganisms such as tuberculosis bacteria, which grow very slowly in the culture dish.

Scientists headed by Dr. Jens-Peter Knemeyer of the Division of Functional Genome Analysis at the DKFZ have combined a hybridization method, where small DNA probes bind highly specifically and exclusively to the mutated gene sequence, with confocal microscopy technology. The DNA probes are coupled to a fluorescent dye that flashes under laser light. However, this light signal is emitted only if the probe attaches to the target sequence in the bacterial genetic material. ‘Unbound’ probe molecules do not emit a signal. Each of these tiny light flashes that occur when the probe and the target molecule bind to each other, detects a single mutated DNA molecule.

By measuring the duration and decay times of the light flashes, the researchers distinguish between real measurement results and the ubiquitous background fluorescence: Due to chemical properties of the molecules involved, spontaneous fluorescence decays much more quickly than the signal emitted by the dye-labeled probe.

Detection of resistance causing point mutations in the genetic material of the tuberculosis bacterium is just one of numerous possible applications of the new method called single-molecule fluorescence spectroscopy. The method has a big advantage: Instead of recording light flashes in a sample solution, as is done in antibiotic resistance detection, the investigation method can also be used in living cells. Dr. Jörg Hoheisel, head of the Division of Functional Genome Analysis at the DKFZ, explains: “Just as we can detect DNA mutations, we can also use suitable probes to detect all molecules in a cell that are characteristic of a specific disease. Since the test identifies single molecules, it is highly sensitive – but reliable at the same time, because we have an internal control using the decay times.”

Media Contact

Julia Rautenstrauch alfa

More Information:

http://www.dkfz.de

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

A new look at the consequences of light pollution

GAME 2024 begins its experiments in eight countries. Can artificial light at night harm marine algae and impair their important functions for coastal ecosystems? This year’s project of the training…

Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work

Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…

New SPECT/CT technique shows impressive biomarker identification

…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…

Partners & Sponsors